Storbritannien - engelska - myHealthbox

dr. reddy’s laboratories (uk) ltd. - bosentan - film-coated tablet - 125mg - other antihypertensives - treatment of pulmonary arterial hypertension (pah) to improve exercise capacity and symptoms in patients with who functional class iii. efficacy has been shown in: • primary (idiopathic and heritable) pulmonary arterial hypertension • pulmonary arterial hypertension secondary to scleroderma without significant interstitial pulmonary disease • pulmonary arterial hypertension associated with congenital systemic-topulmonary shunts and eisenmenger’s physiology

Storbritannien - engelska - MHRA (Medicines & Healthcare Products Regulatory Agency)

zentiva pharma uk ltd - bosentan monohydrate - oral tablet - 62.5mg

Storbritannien - engelska - MHRA (Medicines & Healthcare Products Regulatory Agency)

milpharm ltd - bosentan monohydrate - oral tablet - 62.5mg

Nya Zeeland - engelska - Medsafe (Medicines Safety Authority)

dr reddy's new zealand limited - bosentan monohydrate 129.082mg equivalent to bosentan 125 mg - film coated tablet - 125 mg - active: bosentan monohydrate 129.082mg equivalent to bosentan 125 mg excipient: ethylcellulose glycerol magnesium stearate maize starch opadry yellow 03k82318 povidone sodium starch glycolate starch - the medicine is indicated for the treatment of idiopathic pulmonary arterial hypertension, familial pulmonary arterial hypertension, pulmonary arterial hypertension associated with scleroderma or pulmonary arterial hypertension associated with congenital systemic to pulmonary shunts including eisenmenger's physiology in patients with who class iii or iv symptoms.

Nya Zeeland - engelska - Medsafe (Medicines Safety Authority)

dr reddy's new zealand limited - bosentan monohydrate 64.541mg equivalent to bosentan 62.5 mg - film coated tablet - 62.5 mg - active: bosentan monohydrate 64.541mg equivalent to bosentan 62.5 mg excipient: ethylcellulose glycerol magnesium stearate maize starch opadry yellow 03k82318 povidone sodium starch glycolate starch - the medicine is indicated for the treatment of idiopathic pulmonary arterial hypertension, familial pulmonary arterial hypertension, pulmonary arterial hypertension associated with scleroderma or pulmonary arterial hypertension associated with congenital systemic to pulmonary shunts including eisenmenger's physiology in patients with who class iii or iv symptoms.

Storbritannien - engelska - MHRA (Medicines & Healthcare Products Regulatory Agency)

viatris uk healthcare ltd - bosentan monohydrate - oral tablet - 125mg

Storbritannien - engelska - MHRA (Medicines & Healthcare Products Regulatory Agency)

milpharm ltd - bosentan monohydrate - oral tablet - 125mg

Storbritannien - engelska - MHRA (Medicines & Healthcare Products Regulatory Agency)

accord-uk ltd - bosentan monohydrate - oral tablet - 125mg

Storbritannien - engelska - MHRA (Medicines & Healthcare Products Regulatory Agency)

dr reddy's laboratories (uk) ltd - bosentan monohydrate - oral tablet - 125mg

Storbritannien - engelska - MHRA (Medicines & Healthcare Products Regulatory Agency)

viatris uk healthcare ltd - bosentan monohydrate - oral tablet - 62.5mg